Liver study tests drug safety in 35 volunteers
NCT ID NCT06812780
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 25 times
Summary
This study looked at how the drug AZD2389 behaves in people with stable liver disease compared to healthy adults. Researchers gave a single dose to 35 participants and measured drug levels in the blood. The goal was to understand safety and how the liver affects drug processing, not to treat the liver condition itself.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATIC IMPAIRMENT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Chandler, Arizona, 85225, United States
-
Research Site
Rialto, California, 92377, United States
-
Research Site
Miami Lakes, Florida, 33014, United States
-
Research Site
Orlando, Florida, 32809, United States
-
Research Site
San Antonio, Texas, 78215, United States
Conditions
Explore the condition pages connected to this study.